Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
8 results
Language : Français
Active substance : trastuzumab
Topics : Diseases and conditions
OK
Chercher
Filter
Topic
Diseases and conditions
(8)
Plus ...
Breast diseases
(5)
Plus ...
Breast cancers
(5)
Digestive system diseases
(2)
Plus ...
Digestive system cancers
(2)
Heart diseases
(2)
Plus ...
Heart failure
(2)
Respiratory tract diseases
(1)
Plus ...
Respiratory tract cancers
(1)
Cancers - miscellaneous
(1)
Diagnostic and therapeutic techniques
(6)
Plus ...
Drug therapy
(5)
Diagnostic techniques and procedures
(1)
Plus ...
Medical imaging
(1)
Economics and public health
(3)
Plus ...
Organisation of care
(1)
Health economics
(1)
Screening, prevention
(1)
Content type
Drugs, devices and medical acts
(5)
Plus ...
Medicine
(4)
Health technology assessment
(1)
Practice Guidelines and Other Guides
(3)
Plus ...
Chronic disease guide
(2)
Practice guidelines
(1)
Date
Last five years
(4)
Manufacturer
inconnu
(1)
industriels
(1)
Language
Français
(8)
Active substance
acide folique
(1)
alcool
(3)
alemtuzumab
(1)
apixaban
(2)
aspirine
(2)
chlorure de sodium
(1)
cibenzoline
(2)
cilazapril
(1)
ciprofloxacine
(1)
cisplatine
(1)
cuivre
(1)
cyclophosphamide
(1)
disopyramide
(2)
fosinopril
(1)
gadobutrol
(1)
gadodiamide
(1)
gadolinium
(1)
gemcitabine
(1)
hydrocortisone
(1)
ifosfamide
(1)
iobitridol
(1)
iode
(1)
iodixanol
(1)
iohexol
(1)
iopamidol
(1)
iopromide
(1)
ioversol
(1)
lithium
(2)
losartan
(1)
oxaliplatine
(1)
paclitaxel
(1)
pentostatine
(1)
potassium
(1)
ramipril
(1)
rituximab
(1)
rivaroxaban
(2)
spironolactone
(1)
trastuzumab
(8)
tyrosine
(2)
More filter
Save your search
Practice guidelines and other guides
- 3 results
Chronic symptomatic heart failure with preserved systolic function
Chronic disease guide
- Posted on 24/7/2015
Add to
my selection
Symptomatic chronic systolic heart failure
Chronic disease guide
- Posted on 24/7/2015
Add to
my selection
Patient selection criteria for at-home cancer chemotherapy
Practice guidelines
- Posted on 1/9/2003 - Mis à jour le 30/10/2006
Download
abstract
Add to
my selection
Drugs, devices and medical acts
- 5 results
Usefulness of contrast-enhanced mammography in breast cancer diagnosis strategy - INAHTA Brief
Health technology assessment
- Posted on 22/11/2021 - Mis à jour le 22/11/2021
Download
document
Add to
my selection
ENHERTU (trastuzumab déruxtécan)
Medicine
- Posted on 18/7/2024
Add to
my selection
PHESGO (pertuzumab, trastuzumab)
Medicine
- Posted on 8/4/2021
Add to
my selection
KADCYLA
Medicine
- Posted on 12/6/2020 - Mis à jour le 12/6/2020
Add to
my selection
HERCEPTIN (trastuzumab)
Medicine
- Posted on 28/9/2016 - Mis à jour le 12/6/2019
Add to
my selection
See 5 result in Drugs, devices and medical acts
Français
English
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
ea70FjA5a2R9nvnw